Literature DB >> 226996

Biogenesis of poxviruses: role for the DNA-dependent RNA polymerase II of the host during expression of late functions.

M Silver, G McFadden, S Wilton, S Dales.   

Abstract

The participation of host RNA polymerase II in the vaccinia life cycle was examined by comparing efficiency of multiplication after treating the Ama+ sensitive and Ama 102 drug resistant lines with alpha-amanitin. In the latter, resistance is due to a mutation in RNA polymerase II. The toxin profoundly reduces synthesis of virus-specified polypeptides and morphopoeisis in Ama+ but not in Ama 102 rat myoblasts without appreciably altering vaccinia DNA replication in either cell type. This implicates RNA polymerase II in the expression of late virus functions. Circumstantial evidence from a model system indicates that gamma irradiation of the host prior to infection might disrupt transcription into functional mRNA from the nucleus. Irradiation does not, however, alter the capability of the host to support vaccinia multiplication fully. Therefore, ongoing host nuclear transcription may not be required by this virus. The above results are consistent with the ability of cytoplasts to produce small quantities of mature progeny. Our studies lead us to hypothesize that RNA polymerase II or a subunit of the host enzyme may participate directly in late transcription of the vaccinia genome.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 226996      PMCID: PMC383990          DOI: 10.1073/pnas.76.8.4122

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Biogenesis of poxviruses: analysis of the morphogenetic sequence using a conditional lethal mutant defective in envelope self-assembly.

Authors:  W Stern; B G Pogo; S Dales
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

2.  Biogenesis of vaccinia: relationship of the envelope to virus assembly.

Authors:  W Stern; S Dales
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

3.  Isolation and partial characterization of the poly(A) polymerases from HeLa cells infected with vaccinia virus.

Authors:  J R Nevins; W K Joklik
Journal:  J Biol Chem       Date:  1977-10-10       Impact factor: 5.157

4.  Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis.

Authors:  Y Ichihashi; S Dales
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

5.  Vaccinia as a model for membrane biogenesis.

Authors:  S Dales; E H Mosbach
Journal:  Virology       Date:  1968-08       Impact factor: 3.616

6.  Biogenesis of vaccinia: isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects.

Authors:  S Dales; V Milovanovitch; B G Pogo; S B Weintraub; T Huima; S Wilton; G McFadden
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

7.  Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination.

Authors:  Y Ichihashi; S Matsumoto; S Dales
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

8.  Vaccinia virus replication. I. Requirement for the host-cell nucleus.

Authors:  D E Hruby; L A Guarino; J R Kates
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

9.  Vaccinia virus replication requires active participation of the host cell transcriptional apparatus.

Authors:  D E Hruby; D L Lynn; J R Kates
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

10.  Synthesis of influenza virus polypeptides in cells resistant to alpha-amanitin: evidence for the involvement of cellular RNA polymerase II in virus replication.

Authors:  R A Lamb; P W Choppin
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

View more
  13 in total

1.  Intracellular location of rabbit poxvirus nucleic acid within infected cells as determined by in situ hybridization.

Authors:  H Minnigan; R W Moyer
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

2.  Isolation and characterization of monoclonal antibodies directed against two subunits of rabbit poxvirus-associated, DNA-directed RNA polymerase.

Authors:  D K Morrison; J K Carter; R W Moyer
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

3.  Molecular dissection of cis-acting regulatory elements from 5'-proximal regions of a vaccinia virus late gene cluster.

Authors:  J N Miner; S L Weinrich; D E Hruby
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Mapping the genomic location of the gene encoding alpha-amanitin resistance in vaccinia virus mutants.

Authors:  E C Villarreal; D E Hruby
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

5.  The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.

Authors:  Jitka Holcakova; Peter Tomasec; Joachim J Bugert; Eddie Cy Wang; Gavin Wg Wilkinson; Roman Hrstka; Vladimir Krystof; Miroslav Strnad; Borivoj Vojtesek
Journal:  Antivir Chem Chemother       Date:  2010-01-05

6.  A cellular factor is required for transcription of vaccinia viral intermediate-stage genes.

Authors:  R Rosales; G Sutter; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Vaccinia virus RNA polymerase associated with nuclei of infected HeLa cells.

Authors:  D Wing; A Weissbach
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

8.  Biochemical and genetic characterization of vaccinia virus temperature-sensitive mutants with DNA- and DNAf-phenotypes.

Authors:  V I Chernos; N V Chelyapov; T P Antonova; N N Vasiljeva; I V Mitina
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

9.  Isolation of vaccinia virus mutants capable of replicating independently of the host cell nucleus.

Authors:  E C Villarreal; N A Roseman; D E Hruby
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

10.  Relationship between RNA polymerase II and efficiency of vaccinia virus replication.

Authors:  S Wilton; S Dales
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.